Pseudotyped retrovirus with modified ebola glycoprotein

Details Pseudotyped retrovirus with modified ebola glycoprotein Pseudotyped retrovirus with modified ebola glycoprotein

2011-07-19

2011-07-19

Peng, Bo (Department: 1648)

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

C977S802000, C977S803000, C536S023100

Reexamination Certificate

active

07981656

ABSTRACT:
Pseudotyped retroviruses having viral glycoproteins with modified O glycosylation regions are provided. Also provided are methods for making the pseudotyped retroviruses of the present invention and for using the pseudotyped retroviruses for transduction of target cells. Cells for stably producing the pseudotyped retroviruses or the present invention are also provided.

REFERENCES:
patent: 4912030 (1990-03-01), Weiss et al.
patent: 5185440 (1993-02-01), Davis et al.
patent: 5278056 (1994-01-01), Bank et al.
patent: 5491084 (1996-02-01), Chalfie et al.
patent: 5503974 (1996-04-01), Gruber et al.
patent: 5512421 (1996-04-01), Burns et al.
patent: 5591624 (1997-01-01), Barber et al.
patent: 5681746 (1997-10-01), Bodner et al.
patent: 5723287 (1998-03-01), Russell et al.
patent: 5723333 (1998-03-01), Levine et al.
patent: 5739018 (1998-04-01), Miyanohara et al.
patent: 5747243 (1998-05-01), Gruber et al.
patent: 5750396 (1998-05-01), Yang et al.
patent: 5910434 (1999-06-01), Rigg et al.
patent: 6306434 (2001-10-01), Hong et al.
patent: 7033595 (2006-04-01), Sanders et al.
patent: 2005/0112098 (2005-05-01), McCray, Jr. et al.
patent: WO 00/08131 (2000-02-01), None
patent: WO 00/08131 (2000-06-01), None
patent: WO 01/83730 (2001-11-01), None
patent: WO 01/83730 (2002-05-01), None
patent: WO 03/014367 (2003-02-01), None
patent: WO 03/035849 (2003-05-01), None
patent: WO 03/035849 (2003-10-01), None
patent: WO 03/102219 (2003-12-01), None
patent: WO 03/102219 (2004-10-01), None
Kobinger GP et al. “Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo”. Nat Biotechnol. Mar. 2001;19(3):225-30.
Soneoka Y, et al. “A transient three-plasmid expression system for the production of high titer retroviral vectors.” Nucleic Acids Res. Feb. 25, 1995;23(4):628-33.
Brindley, Ma et al “Ebola Virus Glycoprotein 1: Identification of Residues Important for Binding and Postbinding Events” J. Virol. 2007 81: 7702-7709.
Yang S, et al. “Generation of retroviral vector for clinical studies using transient transfection.” Hum Gene Ther. Jan. 1, 1999;10(1):123-32.
Abell and Brown, “Sindbis virus membrane fusion is mediated by reduction of glycoprotein disulfide bridges at the cell surface,” Sep. 1993J. Virol. 67(9):5496-5501.
Cassell et al., “Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus,” Dec. 1984J. Virol52(3):857-864.
Chalfie et al., “Green fluorescent protein as a marker for gene expression,” Feb. 11, 1994Science263(5148):802-805.
Cheng et al., “Nucleocapsid and glycoprotein organization in an enveloped virus,” Feb. 24, 1995Cell80:621-630.
Chepurnov et al., “Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein,” Jun. 1, 1999Immunol. Lett. 68(2-3):257-261.
DeTulleo and Kirchhausen, “The clathrin endocytic pathway in viral infection,” 1998EMBO J. 17(16):4585-4593.
“The DNA and RNA Reverse Trascribing Viruses,” [online]. The International Committee on Taxonomy of Viruses, Apr. 21, 1998 [retrieved Jun. 3, 2003]. Retrieved from the Internet: http://www.ncbi.nlm.nih.gov/ICTV/overview/dnaandrna.html>; 1 pg.
Flynn et al., “A conformational change in Sindbis virus glycoproteins E1 and E2 is detected at the plasma membrane as a consequence of early virus-cell interaction,” Aug. 1990J. Virol. 64(8):3643-3653.
Fuller, “The T=4 envelope of Sindbis virus is organized by interactions with a complementary T=3 capsid,” Mar. 27, 1987Cell48:923-934.
Gaedigk-Nitschko and Schlesinger, “The sindbis virus 6K protein can be detected in virions and is acylated with fatty acids,” Mar. 1990Virology175(1):274-281.
Gallardo et al., “Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoportein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes,” Aug. 1, 1997Blood90(3):952-957.
Glomb-Reinmund and Kielian, “The role of low pH and disulfide shuffling in the entry and fusion of Semliki Forest virus and Sindbis virus,” Sep. 1, 1998Virology248(2):372-381.
Havenga et al., “Development of safe and efficient retroviral vectors for Gaucher disease,” Dec. 1997Gene Therapy4(12):1393-1400.
Liu et al., “Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer,” Apr. 1996J. Virol. 70(4):2497-2502.
McCray, Paul “Gene Transfer to Human Airway Epithelia In Vivo,” Grant Abstract, Grant No. 2PO1HL051670-06A10005 [online]. National Institutes of Health: National Heart, Lung, and Blood Institute, project datesApr. 1, 1999 to Mar. 31, 2000 [retrieved on Jan. 26, 2005]. Retrieved from the Internet: <http://crisp.cit.nih.gov/crisp/CRISP—LIB.getdoc?textkey=6110285&p—grant—num=2P01HL051670-06A10005&p—query=&ticket=50955150&p—audit—session—d=278722693&p—keywords=>; 2 pgs.
McCray, Paul “Gene Transfer to Human Airway Epithelia In Vivo,” Grant Abstract, Grant No. 5PO1HL051670-070005 [online]. National Institutes of Health: National Heart, Lung, and Blood Institute, project dates Jul. 1, 2000 to Mar. 31, 2001 [retrieved on Jan. 26, 2005]. Retrieved from the Internet: <http://crisp.cit.nih.gov/crisp/CRISP—LIB.getdoc?textkey=6325956&p—grant—num=5P01HL051670-070005&p—query=&ticket=50955150&p—audit—session—id=278722693&p—keywords=>; 2 pgs.
McCray, Paul “Gene Transfer to Human Airway Epithelia In Vivo,” Grant Abstract, Grant No. 5PO1HL051670-080005 [online]. National Institutes of Health: National Heart, Lung, and Blood Institute, project dates Aug. 1, 2001 to Mar. 31, 2002 [retrieved on Jan. 26, 2005]. Retrieved from the Internet: <http://crisp.cit.nih.gov/crisp/CRISP—LIB.getdoc?textkey=6485289&p—grant—num=5P01HL051670-080005&p—query=&ticket=50955150&p—audit—session—id=278722693&p—keywords=>; 2 pgs.
McCray, Paul “Gene Transfer to Human Airway Epithelia In Vivo,” Grant Abstract, Grant No. 5PO1HL051670-090005 [online]. National Institutes of Health: National Heart, Lung, and Blood Institute, project dates Apr. 1, 2002 to Mar. 31, 2003 [retrieved on Jan. 26, 2005]. Retrieved from the Internet: <http://crisp.cit.nih.gov/crisp/CRISP—LIB.getdoc?textkey=6581185&p—grant—num=5P01HL051670-090005&p—query=&ticket=50955150&p—audit—session—id=278722693&p—keywords=>; 2 pgs.
McCray, Paul “Gene Transfer to Human Ainvay Epithelia In Vivo,” Grant Abstract, Grant No. 5PO1HL051670-100005 [online]. National Institutes of Health: National Heart, Lung, and Blood Institute, project dates unlisted [retrieved on Jan. 26, 2005]. Retrieved from the Internet: <http://crisp.cit.nih.gov/crisp/CRISP—LIB.getdoc?textkey=6729317&p—grant—num=5P01HL051670-100005&p—query=&ticket=50955150&p—audit—session—id=278722693&p—keywords=>; 2 pgs.
McCray, Paul “Targeting Entry in Epithelia with ICMV-FIV,” Grant Abstract, Grant No. 2PO1HL051670-110005 [online]. National Institutes of Health: National Heart, Lung, and Blood Institute, project dates Apr. 1, 2004 to Mar. 31, 2009 [retrieved on Jan. 26, 2005]. Retrieved from the Internet: <http://crisp.cit.nih.gov/crisp/CRISP—LIB.getdoc?textkey=6853152&p—grant—num=2PO1HL051670-110005&p—query=&ticket=50955150&p—audit—session—id=

Affiliated with

Also associated with

Rating

Pseudotyped retrovirus with modified ebola glycoprotein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pseudotyped retrovirus with modified ebola glycoprotein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pseudotyped retrovirus with modified ebola glycoprotein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2618704